Symbols

SGRY

Surgery Partners·NASDAQ

--(--)

SGRY fundamentals

SGRY Q4 2025 Earnings

Surgery Partners (SGRY) released its earnings on Mar 2, 2026: revenue was 885.00M (YoY +2.38%), beat estimates; EPS was 0.12 (YoY -72.73%), missed estimates.

Revenue / YoY

885.00M

+2.38%

EPS / YoY

0.12

-72.73%

Report date

Mar 2, 2026

SGRY Earnings Call Summary for Q4,2025

Revenue Growth: 2025 net revenue $3.3 billion (+6.2% YoY), but Q4 EBITDA miss due to Medicare mix shift and 3 underperforming surgical hospitals.
2026 Outlook: Revenue $3.35-$3.45 billion, EBITDA $530+ million. Includes $8M state tax and $4M tariff headwinds, plus $9M M&A contribution.
Strategic Moves: $200M share buyback authorized; 8 new ASCs opened in 2025, 5 under construction. Baylor JV example of portfolio optimization.
Growth Drivers: Orthopedics (15% Q4 total joint growth), robotics (74 surgical robots), and vascular expansion. 2026 focus on physician recruitment, cost containment, and de novo development.

Earnings

EPS

Revenue

Revenue & Expenses

SGRY has released its 2025 Q4 earnings report, with revenue of 885.00M, reflecting a YoY change of 2.38%, and net profit of 29.00M, showing a YoY change of 162.23%. The Sankey diagram below clearly presents SGRY's revenue sources and cost distribution.

Key Indicators

Surgery Partners (SGRY) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Surgery Partners (SGRY)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Surgery Partners (SGRY)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Surgery Partners (SGRY)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown